New Relapse Model in Psychiatry
NRMP
Creation of a Visualization Tool With Integrated Clinical Data to Support Clinical Intervention and Empowerment of Inpatients in Psychiatry : Basis for the Development of a Predictive Model of Relapse
1 other identifier
interventional
350
1 country
1
Brief Summary
The goal of this clinical trial is to learn about risk factors of relapse in patients with alcohol use disorder. The main questions it aims to answer are :
- Among patients with Alcohol Use Disorder, are there clusters of patients with the same characteristics and the same outcome ?
- Which are the risk factors of relapse that are the most predictive ? Do they vary according to cluster?
- Can a feedback-measurment-system (eg : a feedback of the tests' results) be usefull in a detoxification unit ? Participants will :
- Complete auto-questionnaires
- Pass hetero-evaluations
- Undergo an electrophysiological battery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2024
CompletedStudy Start
First participant enrolled
November 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
April 27, 2026
April 1, 2026
2.4 years
January 29, 2024
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relapse or abstinence after detoxification
number of alcohol units and time to relapse or abstinence after detoxification
Throughout the entire study, approximately during 48 months
Secondary Outcomes (1)
Satisfaction of the feedback-measurment-system for clinicians and patients
Throughout the entire study, approximately during 48 months
Study Arms (1)
Intervention
EXPERIMENTALInterventions
Evaluations of risk factors of relapse by questionnaires, evaluation of evoked-potentials
Eligibility Criteria
You may qualify if:
- To suffer from AUD
- To be hospitalized
- To speak French fluently
- To be able to give their consent (medically and legally).
You may not qualify if:
- To suffer from severe perceptive disabilities (auditory, visual)
- To suffer from severe cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, 1200, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe de Timary, PhD
Université catholique de Louvain (Wallonia)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 6, 2024
Study Start
November 12, 2024
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
February 1, 2028
Last Updated
April 27, 2026
Record last verified: 2026-04